Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis.

ABSTRACT:

Background/aims

Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear.

Methods

We identified articles reporting about the clinical presentation of COVID-19 in those with underlying IBD from PubMed and Embase. The studies, irrespective of design or language, were included. The overall pooled frequency of various symptoms was estimated. Joanna Briggs Institute Critical appraisal checklist was used to assess the quality of studies.

Results

Eleven studies, including 1,325 patients, were included in the pooled analysis. The pooled estimates for clinical presentation were; fever: 67.53% (95% confidence interval [CI], 45.38-83.88), coug

SUBMITTER: Singh AK 

PROVIDER: S-EPMC8831773 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature